poisar

Stock

Vivani Medical, Inc. Common Stock (DE) VANI

$1.40-1.06%

Overview

VANI market data

Price History

VANI price chart · 3M
O
1.41
H
1.42
L
1.40
C
1.40
Vol
4,425.00
Source
US equities market feed
Observed
Aug 27, 2026, 12:00 AM
Cadence
Five-minute page cache; daily and stored hourly bars
Status
fresh

Key Stats & Performance

Open
$1.41
Previous Close
$1.41
Day High
$1.42
Day Low
$1.40
52 Week High
$1.66
52 Week Low
$1.10
7 Day Return
-0.71%
30 Day Return
+6.90%
90 Day Return
+5.28%
1 Year Return
+5.68%
Daily Notional Volume
$6.2K
Latest daily bar volume multiplied by its closing price.

Valuation & Profitability

Provider-backed
P/E (TTM)
Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
Forward P/E
P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
EPS (TTM)
-$0.42
Diluted earnings per share over the trailing twelve months.
Beta
2.39
Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
Dividend Yield
Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
Profit Margin
-993.8%
Net income divided by revenue. Comparable within a sector, less so across sectors.
52w range
$0.92 – $1.92
Lowest and highest closing prices over the past 52 weeks.
Analyst Target
Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.

Display-only. Refreshed once per symbol per 24 hours · market cap $111.5M · P/B 5.70 · P/S 32.98.

Company News

8 captured
8-K filing — Vivani Medical, Inc. (VANI)SEC EDGAR · Aug 17, 2026, 12:00 PM
Vivani Medical Q2 EPS $(0.07) Beats $(0.08) EstimateBenzinga · Aug 13, 2026, 8:21 PM
Presenting on Emerging Growth Conference 94 Day 1 on July 15; Register to live streamGlobenewswire Inc · Jul 14, 2026, 11:15 AM
Vivani Medical To Allow Novo Nordisk To Evaluate NPM-139, The Company’s Semaglutide Drug ImplantBenzinga · Jul 7, 2026, 11:45 AM
Vivani Announces Entry into Merger Agreement Between Wholly Owned Subsidiary Cortigent, Inc. and Nasdaq-listed ClearOne, Inc.Globenewswire Inc · Jul 2, 2026, 12:15 PM
ClearOne To Acquire Vivani Medical Subsidiary Cortigent For 12.5M Shares Of CLRO Worth ~$40.4M; ClearOne To File S-1 Seeking To Raise $10M-$15MBenzinga · Jul 2, 2026, 12:10 PM
Vivani Medical Receives Approval From Australian Human Research Ethics Committee Bellberry To Initiate SLIM-1, A Phase 1 Clinical Trial Of Semaglutide Implant NPM-139Benzinga · Jun 25, 2026, 11:40 AM
Lake Street Initiates Coverage On Vivani Medical with Buy Rating, Announces Price Target of $4Benzinga · Jun 23, 2026, 2:30 PM

Decision & Score

Members

Our Tradable / Watch / Avoid decision and 0–100 conviction score for this symbol are members-only.

Create account to unlock

Trend & Pattern Evidence

Members

Trend alignment and backtested chart-pattern probabilities are members-only.

Create account to unlock

Sector Peer Ranking

Members

Ranked sector peers with scores and decisions are members-only.

Create account to unlock
Vivani Medical, Inc. Common Stock (DE) (VANI) stock — price, valuation & news | Poisar